BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 110406
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110406
Table 1 Comparison of baseline clinical characteristics in type 2 diabetes mellitus patients grouped according to metabolic dysfunction-associated steatotic liver disease status, mean ± SD/n (%)
Variables
Total (n = 688)
Non-MASLD (n = 345)
MASLD (n = 343)
P value
Age (years)56.71 ± 12.7359.97 ± 11.953.44 ± 12.72< 0.001
BMI (kg/m2)25.16 ± 3.6423.88 ± 3.2126.45 ± 3.59< 0.001
SBP (mmHg)129.38 ± 18.11128.11 ± 18.75130.66 ± 17.370.064
DBP (mmHg)78.37 ± 11.5675.43 ± 11.181.33 ± 11.27< 0.001
HbA1c (%)9.10 ± 2.299.08 ± 2.509.12 ± 2.060.835
WBC (× 109/L)6.35 ± 1.716.11 ± 1.556.60 ± 1.82< 0.001
RBC (× 1012/L), median (Q1, Q3)4.57 (4.22, 4.94)4.46 (4.09, 4.85)4.70 (4.35, 5.03)0.291
PLT (× 109/L)190.45 ± 56.48186.71 ± 61.13194.20 ± 51.190.083
TP (g/L)65.23 ± 5.6264.75 ± 5.5365.72 ± 5.680.024
ALT (U/L)29.08 ± 30.0923.61 ± 29.1234.59 ± 30.09< 0.001
AST (U/L)24.99 ± 23.8522.13 ± 16.2527.87 ± 29.340.002
BUN (mmol/L)6.69 ± 2.357.13 ± 2.46.24 ± 2.21< 0.001
TC (mmol/L)4.72 ± 1.444.57 ± 1.474.87 ± 1.390.007
TG (mmol/L)2.33 ± 2.681.76 ± 1.672.91 ± 3.31< 0.001
HDL-C (mmol/L)1.10 ± 0.321.14 ± 0.271.06 ± 0.35< 0.001
LDL-C (mmol/L)2.82 ± 0.932.71 ± 0.882.93 ± 0.970.003
FBG (mmol/L)8.51 ± 3.878.48 ± 4.418.53 ± 3.240.863
ZJU index40.07 ± 7.0337.88 ± 6.6742.27 ± 6.7< 0.001
Scr (mmol/L)61.00 (49, 72)61.00 (50, 75)60.00 (49, 70)0.143
UA (mmol/L), median (Q1, Q3)326.00 (267.5, 386)310.00 (255, 372)346.00 (284, 409.5)< 0.001
Sex (male)458 (66.57)221 (64.06)237 (69.1)0.161
Smoking254 (36.92)120 (34.78)134 (39.07)0.244
Drinking272 (39.53)115 (33.33)157 (45.77)< 0.001
Hypertension360 (52.33)172 (49.86)188 (54.81)0.193
CAD71 (10.32)46 (13.33)25 (7.29)0.009


Write to the Help Desk